Alison Center

Latest from Alison Center

eBook: mRNA — Revisiting a Technology That Has Rocketed into Success
Manufacturing
eBook: mRNA — Revisiting a Technology That Has Rocketed into SuccesseBook: mRNA — Revisiting a Technology That Has Rocketed into Success
byAlison Center, S. Anne Montgomeryand 4 more
Apr 28, 2021
Monoclonal Antibodies: Beyond the Platform in Manufacturing
MAb
Monoclonal Antibodies: Beyond the Platform in ManufacturingMonoclonal Antibodies: Beyond the Platform in Manufacturing
byAlison Center, Cheryl Scott
Mar 29, 2019

All from Alison Center

Continuous Chromatography: Experts Weigh in on the Possibilities and the Reality
Continuous Bioprocessing
Continuous Chromatography: Experts Weigh in on the Possibilities and the Reality
Continuous Chromatography: Experts Weigh in on the Possibilities and the Reality
Feb 28, 2019
+1
byS. Anne Montgomery, Cheryl Scottand 1 more
Messenger RNA Drugs: Engaging the Machinery of Patients' Cells to Therapeutic Effect
Manufacturing
Messenger RNA Drugs: Engaging the Machinery of Patients' Cells to Therapeutic Effect
Messenger RNA Drugs: Engaging the Machinery of Patients' Cells to Therapeutic Effect
Dec 22, 2018
byAlison Center, S. Anne Montgomery
Innovators and Biosimilar Companies: Experts Predict Intense Conflicts Ahead logo in a gray background | Innovators and Biosimilar Companies: Experts Predict Intense Conflicts Ahead
Regulatory Affairs
Innovators and Biosimilar Companies: Experts Predict Intense Conflicts Ahead
Innovators and Biosimilar Companies: Experts Predict Intense Conflicts Ahead
Jun 20, 2018
byAlison Center
Facilities of the Future: Intelligent Design and Control Enable Quality, Efficiency, and Good Citizenship
Facility Design/Engineering
Facilities of the Future: Intelligent Design and Control Enable Quality, Efficiency, and Good Citizenship
Facilities of the Future: Intelligent Design and Control Enable Quality, Efficiency, and Good Citizenship
Apr 20, 2018
byAlison Center
Panel Discussion: Emerging Biotherapies and Their Manufacturing Challenges
Sponsored Content
Panel Discussion: Emerging Biotherapies and Their Manufacturing Challenges
Panel Discussion: Emerging Biotherapies and Their Manufacturing Challenges
Aug 8, 2017
byAlison Center
Panel Discussion: How CMO Business Models Have Adapted to Meet the Challenges and Opportunities of Protein-Based and Emerging Therapy Markets
Sponsored Content
Panel Discussion: How CMO Business Models Have Adapted to Meet the Challenges and Opportunities of Protein-Based and Emerging Therapy Markets
Panel Discussion: How CMO Business Models Have Adapted to Meet the Challenges and Opportunities of Protein-Based and Emerging Therapy Markets
Aug 7, 2017
byAlison Center
Panel Discussion: Cell, Gene, and Tissue Therapies — Applying Key Lessons from the Evolution and Commercialization of Protein-Based Therapies
Sponsored Content
Panel Discussion: Cell, Gene, and Tissue Therapies — Applying Key Lessons from the Evolution and Commercialization of Protein-Based Therapies
Panel Discussion: Cell, Gene, and Tissue Therapies — Applying Key Lessons from the Evolution and Commercialization of Protein-Based Therapies
Aug 7, 2017
byAlison Center
Panel Discussion: Process and Business Considerations for Innovation — Supplier and End-User Perspectives
Sponsored Content
Panel Discussion: Process and Business Considerations for Innovation — Supplier and End-User Perspectives
Panel Discussion: Process and Business Considerations for Innovation — Supplier and End-User Perspectives
Aug 7, 2017
byAlison Center
Panel Discussion: Single-Use and Process Development Technologies — Making the Right Choices for Your Process
Sponsored Content
Panel Discussion: Single-Use and Process Development Technologies — Making the Right Choices for Your Process
Panel Discussion: Single-Use and Process Development Technologies — Making the Right Choices for Your Process
Aug 7, 2017
byAlison Center
Panel Discussion: How to Differentiate Your Vaccine Platform in a Competitive Market
Sponsored Content
Panel Discussion: How to Differentiate Your Vaccine Platform in a Competitive Market
Panel Discussion: How to Differentiate Your Vaccine Platform in a Competitive Market
Aug 7, 2017
byAlison Center
Current Thinking in Viral Safety: Risk Management Protects Patients logo in a gray background | Current Thinking in Viral Safety: Risk Management Protects Patients
Viral Clearance
Current Thinking in Viral Safety: Risk Management Protects Patients
Current Thinking in Viral Safety: Risk Management Protects Patients
May 18, 2017
+1
byHazel Aranha, S. Anne Montgomeryand 1 more
Going After a Moving Target: New Production Methods Aid in the Flu Fight logo in a gray background | Going After a Moving Target: New Production Methods Aid in the Flu Fight
Vaccines
Going After a Moving Target: New Production Methods Aid in the Flu Fight
Going After a Moving Target: New Production Methods Aid in the Flu Fight
Apr 13, 2017
byCheryl Scott, Alison Center
Rapid Development of High-Quality, Robust Mammalian Cell Culture Manufacturing Processes
Process Development
Rapid Development of High-Quality, Robust Mammalian Cell Culture Manufacturing Processes
Rapid Development of High-Quality, Robust Mammalian Cell Culture Manufacturing Processes
Sep 15, 2016
byJozef Orpiszewski, Alison Center
Deciding Between Single-Use and Stainless Steel Strategies
Sponsored Content
Deciding Between Single-Use and Stainless Steel Strategies
Deciding Between Single-Use and Stainless Steel Strategies
Aug 11, 2016
+4
byAlison Center, Eric S. Langerand 4 more
Coordination of Single-Use System Standards and Best-Practice Efforts
Sponsored Content
Coordination of Single-Use System Standards and Best-Practice Efforts
Coordination of Single-Use System Standards and Best-Practice Efforts
Aug 11, 2016
+2
byAlison Center, James Vogeland 2 more
Getting the Most in Training for New Technologies
Sponsored Content
Getting the Most in Training for New Technologies
Getting the Most in Training for New Technologies
Aug 11, 2016
+4
byAlison Center, Brian Caineand 4 more
Industrialization and Commercialization of Gene and Cell Therapies
Sponsored Content
Industrialization and Commercialization of Gene and Cell Therapies
Industrialization and Commercialization of Gene and Cell Therapies
Aug 11, 2016
+4
byAlison Center, Mike Wardand 4 more
Making the Correct Outsourcing Decisions
Sponsored Content
Making the Correct Outsourcing Decisions
Making the Correct Outsourcing Decisions
Aug 11, 2016
+4
byAlison Center, Gil Rothand 4 more

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Thermo Fisher WP
Sponsored Content
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells

Nov 21, 2024